Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 17 de 17
Filtrar
Más filtros

Bases de datos
Tipo del documento
Intervalo de año de publicación
1.
Front Endocrinol (Lausanne) ; 15: 1307537, 2024.
Artículo en Inglés | MEDLINE | ID: mdl-38375195

RESUMEN

Background: Light influences the secretion of melatonin in the body and regulates circadian rhythms, which play an important role in sleep and mood. The light level of rooms in long-term care facilities is usually far below the threshold required to regulate the body's circadian rhythm, and insufficient light can easily lead to sleep and mood disturbances among older residents in nursing homes. Therefore, the objective of this study was to investigate the effects of light therapy on sleep and circadian rhythm in older adults with type 2 diabetes residing in long-term care facilities. Methods: This study was a prospective, single-blind, randomized controlled trial. Participants were randomly assigned to either the light therapy (LT) group or the control group and received the intervention for four weeks. Primary outcomes included the Pittsburgh Sleep Quality Index (PSQI) and objective sleep parameters recorded by a sleep monitoring bracelet, Morningness-Eveningness Questionnaire (MEQ). The secondary outcome included glycated serum protein (GSP). Data was collected at three time points: at baseline (T0), immediate post-treatment (T1), and 4-week follow-up (T2). A linear mixed model analysis was used to analyzed the data. Results: We enrolled 45 long-term care residents. Compared with the control group, significant reductions in PSQI scores were observed at T1 and T2. At T2, the sleep score of objective sleep parameters was significantly higher in the LT group compared to the control group. Additionally, compared to the baseline T0, MEQ scores were significantly lower in the LT group at T1 and T2, with no significant difference in the control group. There was no significant difference between groups in glycated serum protein values at T1 and T2. However, compared to T0, glycated serum protein values decreased in the LT group while increased in the control group at T2. Conclusion: Light therapy had a positive effect on subjective sleep quality and circadian rhythm time type in long-term care residents with type 2 diabetes, and had a possible delayed effect on objective sleep. However, no discernible alterations in blood glucose levels were detected in this study.


Asunto(s)
Diabetes Mellitus Tipo 2 , Humanos , Anciano , Diabetes Mellitus Tipo 2/complicaciones , Diabetes Mellitus Tipo 2/terapia , Cuidados a Largo Plazo , Estudios Prospectivos , Método Simple Ciego , Sueño/fisiología , Ritmo Circadiano/fisiología , Fototerapia , Proteínas Séricas Glicadas
2.
Sci Rep ; 8(1): 12646, 2018 08 23.
Artículo en Inglés | MEDLINE | ID: mdl-30140027

RESUMEN

The present study investigated the anti-hyperglycemic and anti-hyperlipidemia effects of the alkaloid-rich extract from Litsea glutinosa barks (CG) in ob/ob mice. CG was orally administrated (50, 100 and 200 mg/kg) to ob/ob mice for 4 weeks. Parameters of glucose metabolism, hepatotoxicity, hyperlipidemia and inflammation were measured. CG was chemically characterized using UPLC-QTOF-MS. CG dose-dependently decreased body and fat weights without reducing average food intake. CG (100-200 mg/kg) significantly reduced the serum levels of fasting glucose, glycosylated hemoglobin (HbAlc) and glycosylated serum protein (GSP). CG increased insulin sensitivity as manifested by decreased fasting serum insulin, reduced homeostasis model assessment-estimated insulin resistance (HOMA-IR) and improved oral glucose tolerance. CG also alleviated dyslipidemia, ameliorated liver steatosis, increased the activity of serum lipase and alleviated inflammation. The activities of liver pyruvate kinase and glucokinase as well as liver content of glycogen were increased after CG treatment. CG was rich in alkaloids and eight main alkaloids were identified, many of which had been demonstrated to possess adequate anti-diabetic activities. These results suggest that the alkaloid-rich extract of CG possesses potential anti-hyperglycemic and anti-hyperlipidemic effects and can be utilized as an effective agent for the treatment of type 2 diabetes.


Asunto(s)
Alcaloides/química , Hipoglucemiantes/uso terapéutico , Hipolipemiantes/uso terapéutico , Litsea/química , Corteza de la Planta/química , Extractos Vegetales/química , Extractos Vegetales/uso terapéutico , Animales , Glucemia/efectos de los fármacos , Proteínas Sanguíneas/metabolismo , Diabetes Mellitus Experimental/tratamiento farmacológico , Diabetes Mellitus Experimental/metabolismo , Hemoglobina Glucada/metabolismo , Glicoproteínas/metabolismo , Hipoglucemiantes/química , Hipolipemiantes/química , Masculino , Ratones , Ratones Endogámicos C57BL , Proteínas Séricas Glicadas
3.
Food Funct ; 6(10): 3307-15, 2015 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-26242486

RESUMEN

INTRODUCTION: Based on the hypoglycemia and hypolipidemia of mulberry leaf and its extracts, we investigated the effect of a novel formula, Sang Tong Jian (STJ), from mulberry leaf on rats with diabetic nephropathy (DN). METHODS: The DN rats were induced by a long-term high-fat diet and a single streptozotocin injection. STJ was introduced for 12 weeks from the presence of hyperglycemia. The fasting blood glucose of DN rats was determined at weeks 5, 7, 9, and 11 respectively. The serum GSP, GHb and lipid profiles were analyzed by using a colorimetric method and ELISA kits. The kidney function of DN rats was demonstrated through the analysis of urine creatinine, urine albumin, serum urea nitrogen, serum creatinine and the creatinine clearance rate. The H-E (haematoxylin and eosin) and PAS (Periodic Acid-Schiff) staining were adopted to exhibit the morphology of the kidney. The TGF-ß1 and p-smad2/3, smad2/3, collagen IV, connexin 43 and E-cadherin were assayed via immunohistochemistry and western blot. RESULTS: STJ significantly decreased the fasting blood glucose (p < 0.01) and the glycation end product (p < 0.05), and regulated dyslipidemia. Inhibition of the thickening of the glomerular basement membrane and amelioration of the kidney function were shown in STJ-treated DN rats. Moreover, STJ decreased the levels of TGF-ß1, collagen IV, connexin 43 and activation of smad2/3 (p < 0.01), and enhanced E-cadherin (p < 0.01) in the kidney of DN rats. CONCLUSION: 12 week administration of STJ improved the metabolic parameters associated with blood glucose and lipid and inhibited the TGF-ß1 signaling pathway, which positively contributed to the amelioration of chronic diabetic kidney disease.


Asunto(s)
Nefropatías Diabéticas/tratamiento farmacológico , Dieta Alta en Grasa , Morus/química , Extractos Vegetales/farmacología , Hojas de la Planta/química , Factor de Crecimiento Transformador beta1/metabolismo , Animales , Glucemia/metabolismo , Proteínas Sanguíneas , Cadherinas/genética , Cadherinas/metabolismo , Diabetes Mellitus Experimental/tratamiento farmacológico , Hemoglobina Glucada/metabolismo , Glicoproteínas/sangre , Riñón/efectos de los fármacos , Riñón/metabolismo , Masculino , Ratas , Ratas Sprague-Dawley , Transducción de Señal , Estreptozocina , Factor de Crecimiento Transformador beta1/antagonistas & inhibidores , Factor de Crecimiento Transformador beta1/genética , Proteínas Séricas Glicadas
4.
J Am Coll Nutr ; 34(2): 108-12, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-25789547

RESUMEN

BACKGROUND: d-Ribose is a popular dietary supplement for humans and the equine because of its crucial role in cellular bioenergetics. However, as a reducing sugar, it has been suggested that ingestion of d-ribose might promote the formation of glycated proteins in vivo with potential adverse consequences. OBJECTIVE: The aim of this study was to examine if d-Ribose would promote the formation of glycated proteins in vivo following exercise in training thoroughbred racehorses. METHODS: Two groups of horses received the supplement (30 and 50 g d-Ribose daily) for 17 weeks, during which period the horses were subjected to low-intensity exercises followed by high-intensity exercises. Blood samples were analyzed for glycated plasma proteins at baseline and following the 2 exercise regimens. RESULTS: This study shows that long-term ingestion of d-Ribose at 30-50 g a day does not promote the formation of glycated plasma proteins in thoroughbred racehorses. Ribose supplementation also protected the horses from cramping while enhancing muscle recovery at the same time. No adverse effects were reported. CONCLUSION: Ribose supplementation is safe and does not cause glycation in vivo. This investigation also establishes safety of d-Ribose in thoroughbred racehorses, suggesting similar implications in humans as well.


Asunto(s)
Suplementos Dietéticos , Glicoproteínas/sangre , Caballos/sangre , Condicionamiento Físico Animal/fisiología , Ribosa/administración & dosificación , Animales , Proteínas Sanguíneas/biosíntesis , Suplementos Dietéticos/efectos adversos , Glicoproteínas/biosíntesis , Humanos , Calambre Muscular/prevención & control , Recuperación de la Función/efectos de los fármacos , Ribosa/efectos adversos , Proteínas Séricas Glicadas
5.
Food Funct ; 6(3): 878-86, 2015 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-25620042

RESUMEN

The present study is to investigate the possible hypoglycemic and hypolipidemic effects of neohesperidin (NHP) derived from Citrus aurantium L. in vivo. KK-A(y) mice were used as the diabetic experimental model, whereas C57BL/6 mice were used as normal control for a 6-week study. Treatment of NHP significantly decreased fasting glucose, serum glucose, and glycosylated serum protein (GSP) in KK-A(y) mice. It significantly elevated oral glucose tolerance and insulin sensitivity and decreased insulin resistance in the diabetic mice. In addition, NHP significantly decreased serum triglycerides (TG), total cholesterol (TCH), leptin level, and liver index in the KK-A(y) mice. NHP also inhibited lipid accumulation in the liver and decreased the size of epididymal adipocyte in the KK-A(y) mice. Gene expression of stearoyl-CoA desaturase 1 (SCD-1) and fatty acid synthase (FAS) were significantly inhibited, whereas the expression of acyl-CoA oxidase (ACOX) was significantly induced by NHP treatment in the liver of KK-A(y) mice. In addition, elevated level of phosphorylation of hepatic AMPK was observed in NHP-treated mice. Therefore, the activation of the AMPK pathway and regulation of its target genes, including SCD-1, FAS, and ACOX, may play important roles in the hypoglycemic and hypolipidemic effects of NHP in vivo, and NHP may have great potential in the prevention of diabetes and its complications.


Asunto(s)
Citrus/química , Diabetes Mellitus Tipo 2/dietoterapia , Dieta para Diabéticos , Suplementos Dietéticos , Hesperidina/análogos & derivados , Hipoglucemiantes/uso terapéutico , Hipolipemiantes/uso terapéutico , Tejido Adiposo Blanco/patología , Adiposidad , Animales , Proteínas Sanguíneas , Diabetes Mellitus Tipo 2/sangre , Diabetes Mellitus Tipo 2/metabolismo , Diabetes Mellitus Tipo 2/patología , Regulación Enzimológica de la Expresión Génica , Glicoproteínas/sangre , Hesperidina/uso terapéutico , Hiperglucemia/prevención & control , Hiperlipidemias/prevención & control , Resistencia a la Insulina , Metabolismo de los Lípidos , Hígado/enzimología , Hígado/metabolismo , Hígado/patología , Masculino , Ratones Endogámicos C57BL , Ratones Mutantes , Distribución Aleatoria , Organismos Libres de Patógenos Específicos , Proteínas Séricas Glicadas
6.
J Ethnopharmacol ; 138(1): 142-9, 2011 Oct 31.
Artículo en Inglés | MEDLINE | ID: mdl-21924344

RESUMEN

ETHNOPHARMACOLOGICAL RELEVANCE: Leaves of Lithocarpus polystachyus Rehd. are used for the treatment of disorders such as diabetes, hypertension, and epilepsy in folk medicine of South China. The possible antidiabetic effects of the leaves were investigated in experimental type 2 and type 1 diabetic rats. MATERIALS AND METHODS: Type 2 diabetic rats received orally three different extracts of Lithocarpus polystachyus Rehd. leaves for 4 weeks (aqueous extract [ST-1], ethanol extract [ST-2], flavonoid-rich fraction [ST-3]). At the end of the experiment biochemical parameters were tested and livers and pancreases were excised for histological study. After the comparison of the pharmacological test results of the three extracts, the one which showed the best bioactivity was further studied to confirm its antidiabetes effect on both type 2 and type 1 diabetic rats. RESULTS: Compared to ST-1 and ST-2, ST-3 had better effects on regulation of blood glucose, glycosylated serum protein, cholesterol, triglyceride, malondialdehyde, superoxide dismutase and attenuation of liver injury in type 2 diabetic rats (p<0.01 or p<0.05). ST-3 administration for four weeks also significantly reduced the fasting serum insulin and C-peptide level and improved the insulin tolerance (p<0.05). In type 1 diabetic rats, ST-3 supplement for three weeks caused significant reduction in fasting blood glucose, total cholesterol, triglyceride, urea nitrogen, creatinine and liver mass, along with significantly inhibiting the decline of insulin level compared to diabetic control (p<0.05 or p<0.01). CONCLUSION: The flavonoid-rich fraction of Lithocarpus polystachyus Rehd. leaves (ST-3) had better beneficial effect than that of the ethanol or aqueous extract in experimental diabetic rats, which means that the bioactivity of the herbal leaves is probably due to the presence of flavonoids. The results also strongly suggest that the antidiabetic effect of ST-3 was possibly through multiple mechanisms of action including blood lipid and antioxidant mediation. The results indicated that the aqueous flavonoid-rich fraction of Lithocarpus polystachyus Rehd. leaves possessed significant protective activity in type 2 and type 1 diabetes.


Asunto(s)
Diabetes Mellitus Experimental/tratamiento farmacológico , Fagaceae/química , Flavonoides/uso terapéutico , Hipoglucemiantes/uso terapéutico , Fitoterapia , Animales , Glucemia/metabolismo , Proteínas Sanguíneas/metabolismo , Proteína C-Reactiva/metabolismo , Colesterol/sangre , Creatinina/sangre , Diabetes Mellitus Experimental/sangre , Diabetes Mellitus Experimental/patología , Flavonoides/farmacología , Glicoproteínas/metabolismo , Hiperglucemia/sangre , Hiperglucemia/tratamiento farmacológico , Hiperglucemia/patología , Hipoglucemiantes/farmacología , Insulina/sangre , Resistencia a la Insulina , Hígado/efectos de los fármacos , Hígado/patología , Masculino , Malondialdehído/sangre , Nitrógeno/sangre , Extractos Vegetales/farmacología , Extractos Vegetales/uso terapéutico , Hojas de la Planta , Ratas , Ratas Sprague-Dawley , Superóxido Dismutasa/sangre , Triglicéridos/sangre , Urea/sangre , Proteínas Séricas Glicadas
7.
J Agric Food Chem ; 59(13): 6906-12, 2011 Jul 13.
Artículo en Inglés | MEDLINE | ID: mdl-21568336

RESUMEN

In an attempt to elevate temperature to facilitate glycation, a nonenzymatic reaction by incubation of bovine serum albumin (BSA) and fructose at 50 °C for 24 h has been developed. As conducted and compared to a routine procedure by incubation of BSA and fructose at 37 °C for 168 h, the reactant fluorescence intensities and SDS-PAGE-detected glycated BSA quantities produced by both test temperatures increased with time of incubation. As the Amadori products and α-dicarbonyl compounds during incubation were quantified, both quantities produced at each temperature also increased with an increase of time of incubation, and their trends of changes at both temperatures were similar. In practical application for the detection and screening of the antiglycative phytochemicals, each of 20 peanut root extracts was introduced to a series of BSA-fructose solutions and incubated at 37 and 50 °C for 168 and 24 h, correspondingly. All extracts exhibited notable activities and varied depending on peanut origins. Pair comparison of the resultant antiglycative activities determined at 37 and 50 °C showed that both determined activities for each peanut root extract deviated limitedly. As further analyzed, SDS-PAGE-detected glycated BSA quantities formed at 50 °C were closely proportional to the antiglycative activities determined on the basis of their fluorescence intensities. It is of merit to demonstrate that fluorescence-based determination of BSA-fructose reactant after incubation at 50 °C for 24 h is practical and time-saving in the detection and screening of antiglycative phytochemicals.


Asunto(s)
Proteínas Sanguíneas/análisis , Fructosa/química , Glicoproteínas/análisis , Plantas/química , Albúmina Sérica Bovina/química , Arachis , Electroforesis en Gel de Poliacrilamida , Glicosilación/efectos de los fármacos , Calor , Extractos Vegetales/química , Raíces de Plantas/química , Albúmina Sérica Bovina/análisis , Proteínas Séricas Glicadas
8.
J Ethnopharmacol ; 132(2): 518-24, 2010 Nov 11.
Artículo en Inglés | MEDLINE | ID: mdl-20816941

RESUMEN

AIM OF THE STUDY: Potentilla discolor Bunge, commonly found at the north temperate and boreal zone, has been used for diabetes in China for a long time. Flavonoids and triterpenoids are two major types of compounds in P. discolor. This study was designed primarily to investigate the effects of total flavonoids extract (TFE) and total triterpenoids extract (TTE) of P. discolor Bunge on blood glucose, lipid profiles and antioxidant parameters on diabetic rats induced by high fat diet and streptozotocin. MATERIALS AND METHODS: High fat diet-fed and streptozotocin-induced diabetic rats were treated with the TFE and TTE for 15 days, respectively. A range of parameters were tested including fasting blood glucose (FBG), serum insulin (SI), blood lipid profile, malondialdehyde (MDA), superoxide dismutase (SOD), glutathione (GSH), glycosylated serum protein (GSP), and nitric oxide (NO). RESULTS: Diabetic rats treated with TFE or TTE had decreased concentration of FBG and GSP compared with the control group. Meanwhile, the levels of serum total cholesterol (TC), triglycerides (TG) and low-density lipoprotein cholesterol (LDL-c) in the TFE or TTE treated diabetic rats were lower, and the high-density lipoprotein cholesterol (HDL-c) level was higher than in the control diabetic rats. Furthermore, the extracts treatment decreased the MDA and NO level, while increased SOD and GSH levels in diabetic rats. Histopathologic examination also showed that the extracts have protective effects on ß-cells in diabetic rats which are supported by the increase of SI. CONCLUSIONS: All these experimental results highlighted the hypoglycemic and hypolipidemic properties of the two extracts from Potentilla discolor Bunge on diabetes and its complications, possibly through a strong antioxidant activity and a protective action on ß-cells.


Asunto(s)
Antioxidantes/farmacología , Diabetes Mellitus Experimental/tratamiento farmacológico , Medicamentos Herbarios Chinos/farmacología , Hiperlipidemias/tratamiento farmacológico , Hipoglucemiantes/farmacología , Hipolipemiantes/farmacología , Potentilla , Animales , Linfocitos B/efectos de los fármacos , Glucemia , Proteínas Sanguíneas/metabolismo , Peso Corporal/efectos de los fármacos , Diabetes Mellitus Experimental/sangre , Grasas de la Dieta/administración & dosificación , Flavonoides/farmacología , Glicoproteínas/metabolismo , Hiperlipidemias/sangre , Insulina/sangre , Lípidos/sangre , Masculino , Fitoterapia , Ratas , Ratas Wistar , Proteínas Séricas Glicadas
9.
J Diabetes Complications ; 24(3): 199-208, 2010.
Artículo en Inglés | MEDLINE | ID: mdl-19230716

RESUMEN

Diabetic cardiomyopathy is associated with high morbidity and mortality of heart failure. Overactivation of the local chymase-Ang II system plays a dominant role in diabetic cardiomyopathy. Astragalus polysaccharide (APS) is used in traditional Chinese medicine to boost immunity. To study the effect of APS on local system of chymase-Ang II in diabetic cardiomyopathy, we investigated APS/normal saline (NS)-administrated streptozotocin-induced diabetic hamsters. After APS/NS administration at a dose of 1 g/kg per day for 10 weeks, hemodynamic parameters, levels of insulin (INS), C-peptide (C-P), glycosylated serum protein (GSP), lipoproteins, myocardial enzymes, and Ang II (plasma and myocardial) were tested; myocardial collagen (type I and III), myocardial ultrastructure, and activities of matrix metalloproteinase (MMPs) were measured; activities and expression of cardiac chymase and ACE were detected by using quantitative real-time RT-PCR and RIA; protein expression of cardiac phosphoric extracellular signal-regulated kinase 1/2 (p-ERK1/2) was measured by Western blot. AP-administrated diabetic hamsters had lower levels of GSP, lipoproteins, myocardial enzymes, myocardial Ang II, expression of collagen I and I/ III, activities of pro-MMP-2 and MMP-2, activities and expression of chymase, and expression of p-ERK1/2 than NS-administrated diabetic hamsters and could better protect the myocardial ultrastructure. There was no difference in hemodynamic parameters between two groups. These results indicate that APS could inhibit diabetic cardiomyopathy in hamsters depending on the suppression of the local cardiac chymase-Ang II system.


Asunto(s)
Astragalus propinquus , Cardiomiopatías/tratamiento farmacológico , Quimasas/efectos de los fármacos , Complicaciones de la Diabetes/tratamiento farmacológico , Fitoterapia , Preparaciones de Plantas/uso terapéutico , Polisacáridos/uso terapéutico , Angiotensina II/análisis , Animales , Glucemia/análisis , Proteínas Sanguíneas/análisis , Cardiomiopatías/enzimología , Colágeno/análisis , Cricetinae , Complicaciones de la Diabetes/enzimología , Diabetes Mellitus Experimental/tratamiento farmacológico , Diabetes Mellitus Experimental/enzimología , Quinasas MAP Reguladas por Señal Extracelular/análisis , Glicoproteínas/análisis , Lipoproteínas/análisis , Masculino , Metaloproteinasa 2 de la Matriz/análisis , Proteínas Séricas Glicadas
10.
Zhongguo Zhong Yao Za Zhi ; 34(9): 1149-54, 2009 May.
Artículo en Chino | MEDLINE | ID: mdl-19685756

RESUMEN

OBJECTIVE: To study the effects of Polygona-polysaccharose (PSP) on blood glucose level and the mechanism of protection on diabetic rats induced by streptozotocin (STZ). METHOD: The animal model of diabetes was established by injecting STZ (60 mg x kg(-1)) into its abdominal cavity. The amount of water drinking, food intake, urinary volume and body weight were measured at the fourth week of the treatment. The blood samples were drawn to determine the indexes of blood glucose (FBG) and Glycosylated serum protein (GSP) and blood serum insulin (INS). Pancreatic pathology was studied with morphological method and immunohistochemical method. The distribution of apoptotic cells and the expression of Caspase-3 were observed by TUNEL and immunohistochemistry. RESULT: The levels of FBG, GSP and the amount of water drinking, food intake, urinary volume in the PSP treated groups were obviously lower than those in the model group while INS increased. PSP decreased the rate of apoptotic cells and the level of Caspase-3. CONCLUSION: PSP can effectivly decrease blood glucose and increase INS. The mechanism may be related with inhibiting islet cell apoptosis and lowering Caspase-3.


Asunto(s)
Diabetes Mellitus Experimental/tratamiento farmacológico , Medicamentos Herbarios Chinos/química , Hipoglucemiantes/farmacología , Polisacáridos/farmacología , Animales , Apoptosis/efectos de los fármacos , Glucemia/metabolismo , Proteínas Sanguíneas , Caspasa 3/metabolismo , Diabetes Mellitus Experimental/sangre , Diabetes Mellitus Experimental/metabolismo , Diabetes Mellitus Experimental/patología , Modelos Animales de Enfermedad , Regulación Enzimológica de la Expresión Génica/efectos de los fármacos , Glicoproteínas/sangre , Hipoglucemiantes/uso terapéutico , Insulina/sangre , Masculino , Polisacáridos/uso terapéutico , Ratas , Proteínas Séricas Glicadas
11.
Phytomedicine ; 16(10): 967-71, 2009 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-19427773

RESUMEN

The antidiabetic effect of the total flavonoids fraction from leaves of Eriobotrya japonica (EJF) was evaluated through normal and streptozotocin-induced diabetic mice with graded oral doses of 150, 300, 450 mg/kg for 7 days or 14 days. The result showed that the dose of 300 mg/kg and 450 mg/kg resulted significant hypoglycemic effect on normal mice, the dose of 300 mg/kg induced significant decrease in plasma glucose concentration (PGC), glycosylated serum protein (GSP), total cholesterol (TC) and triglyceride (TG), and significant increase in superoxide dismutase (SOD) activity and serum insulin level in streptozotocin-diabetic mice. These results suggested that EJF has hypoglycemic potential.


Asunto(s)
Diabetes Mellitus Experimental/tratamiento farmacológico , Eriobotrya/química , Flavonoides/uso terapéutico , Hipoglucemiantes/análisis , Fitoterapia , Animales , Glucemia/efectos de los fármacos , Proteínas Sanguíneas/metabolismo , Cromatografía Líquida de Alta Presión , Flavonoides/aislamiento & purificación , Glicoproteínas/metabolismo , Insulina/sangre , Lípidos/sangre , Masculino , Ratones , Ratones Endogámicos ICR , Extractos Vegetales/química , Extractos Vegetales/farmacología , Extractos Vegetales/uso terapéutico , Hojas de la Planta/química , Espectrometría de Masa por Ionización de Electrospray , Superóxido Dismutasa/sangre , Proteínas Séricas Glicadas
12.
J Ethnopharmacol ; 122(3): 486-91, 2009 Apr 21.
Artículo en Inglés | MEDLINE | ID: mdl-19429317

RESUMEN

For seeking the good natural material to develop new agent to treat diabetes, the total triterpene acid (TTA) fraction extracted from Folium Eriobotryae [leaves of Eriobotrya japonica (Thunb.) Lindl.] was evaluated for its hypoglycemic and hypolipidemic potential through normal, alloxan and streptozotocin-induced diabetic mice administered with graded oral doses (100, 200, 300 mg/(kg day)) for 7 or 14 days. The results showed that a dose of 300 mg/kg of TTA is the most effective dose to cause significant (p<0.01) hypoglycemic and/or hypolipidemic effects on normal, alloxan and streptozotocin-induced diabetic mice. This dose also significantly (p<0.01) lowered the glycosylated serum protein (GSP), total cholesterol (TC) and triglyceride (TG) level in severely diabetic mice. Furthermore, TTA increased the superoxide dismutase activity (SOD) and the serum insulin level of diabetic mice. These evidences indicated that the total triperpene acid fraction from Folium Eriobotryae has a high anti-diabetic potential along with a good hypolipidemic profile.


Asunto(s)
Diabetes Mellitus Experimental/tratamiento farmacológico , Eriobotrya/química , Hipoglucemiantes/uso terapéutico , Hipolipemiantes/uso terapéutico , Fitoterapia , Extractos Vegetales/uso terapéutico , Triterpenos/uso terapéutico , Animales , Glucemia , Proteínas Sanguíneas , Colesterol/sangre , Relación Dosis-Respuesta a Droga , Glicoproteínas/sangre , Hipoglucemiantes/farmacología , Hipolipemiantes/farmacología , Insulina/sangre , Masculino , Ratones , Extractos Vegetales/farmacología , Hojas de la Planta , Superóxido Dismutasa/sangre , Triglicéridos/sangre , Triterpenos/farmacología , Proteínas Séricas Glicadas
13.
J Pharm Pharmacol ; 59(9): 1271-8, 2007 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-17883899

RESUMEN

The protective effect of Kangen-karyu extract and its mechanisms against fructose-induced metabolic syndrome have been investigated using a rat model. Male Wistar rats were fed a high fructose (65%) diet or standard chow for one week, and for two subsequent weeks were treated with 50 or 100 mg kg(-1) body weight/day Kangen-karyu extract or vehicle. Serum glucose, glycosylated protein, triglyceride (TG), total cholesterol, and blood pressure levels of high-fructose-fed rats were increased compared with those of normal rats. However, Kangen-karyu extract ameliorated the high-fructose-induced metabolic syndrome including hyperglycaemia and hypertriglyceridaemia. In addition, the increase of hepatic TG content in rats given the high fructose diet was significantly inhibited with the regulation of sterol regulatory element-binding protein (SREBP)-1 expression by Kangen-karyu extract. On the other hand, peroxisome proliferator-activated receptor alpha and SREBP-2 protein levels were not affected by the feeding of the high fructose diet or Kangen-karyu extract. Moreover, Kangen-karyu extract administration to high-fructose-fed rats markedly reduced the thiobarbituric acid-reactive substance levels in serum, hepatic homogenate, and mitochondria. Furthermore, it inhibited the increase of cyclooxygenase (COX)-2 with the regulation of nuclear factorkappa B (NF-kappaB) and bcl-2 proteins in the liver, suggesting that the protective potential of Kangenkaryu extract against metabolic syndrome would be attributed to the regulation of COX-2, NF-kappaB, and bcl-2 signalling pathways. This study indicated that Kangen-karyu extract significantly improved high-fructose-induced metabolic syndrome such as hyperglycaemia, hyperlipidaemia, and hypertension through the reductions of TG and cholesterol contents with the regulation of hepatic SREBP-1 protein and the NF-kappaB signalling pathway.


Asunto(s)
Medicamentos Herbarios Chinos/farmacología , Síndrome Metabólico/tratamiento farmacológico , Extractos Vegetales/farmacología , Animales , Glucemia/efectos de los fármacos , Presión Sanguínea/efectos de los fármacos , Proteínas Sanguíneas/efectos de los fármacos , Colesterol/metabolismo , Ciclooxigenasa 2/efectos de los fármacos , Ciclooxigenasa 2/metabolismo , Modelos Animales de Enfermedad , Relación Dosis-Respuesta a Droga , Medicamentos Herbarios Chinos/administración & dosificación , Fructosa , Regulación de la Expresión Génica/efectos de los fármacos , Glicoproteínas/efectos de los fármacos , Masculino , Síndrome Metabólico/inducido químicamente , FN-kappa B/metabolismo , Proteínas Proto-Oncogénicas c-bcl-2/metabolismo , Ratas , Ratas Wistar , Transducción de Señal , Proteína 1 de Unión a los Elementos Reguladores de Esteroles/efectos de los fármacos , Proteína 1 de Unión a los Elementos Reguladores de Esteroles/genética , Sustancias Reactivas al Ácido Tiobarbitúrico/metabolismo , Triglicéridos/metabolismo , Proteínas Séricas Glicadas
14.
Zhongguo Zhong Yao Za Zhi ; 30(15): 1179-83, 2005 Aug.
Artículo en Chino | MEDLINE | ID: mdl-16201696

RESUMEN

OBJECTIVE: To investigate the effects of Pantago depressa var. montata. Extract (PDM) on the metabolisms of glucose and lipids in mice as well as the underlined mechanism. METHOD: Fasting serum glucose (FSG) in normal mice was determined after oral administration of PDM. The effects of PDM on diabetic mice induced by alloxan were investigated by observing the changes of glucose tolerance, the contents of FSG, glycosylated serum protein (GSP), total cholesterol (TC), triglyceride (TG), low density lipoprotein cholesterol (LDL-C), high density lipoprotein cholesterol (HDL-C), superoxide dismutase (SOD), malondialdehyde (MDA), nitric oxide (NO) and the injured degree of pancreatic islet. Effects of PDM on the injured human umbilical vein endothelial cell lines (ECV304) induced by H2O2 were also investigated. RESULT: PDM showed no any significant effect on FSG in normal mice. However, in the mice with diabetes induced by alloxan PDM could remarkably decrease serum glucose tolerance, the contents of FSG, GSP, TC, TG and LDL-C and significantly increased the ratio of HDL-C/TC, the activity of SOD and the concentration of NO. The damage of pancreatic islet induced by alloxan was also significantly attenuated by PDM. Furthermore, PDM promoted the viability of injured ECV304, elevated SOD level and reduced the contents of MDA. CONCLUSION: The results in the present study suggest that PDM can significantly attenuate hyperlipidemia and hyperglycemia in diabetic mice, which are probably due to its effects of antioxidation and amelioration of damaged pancreatic islet induced by free radicals.


Asunto(s)
Glucemia/metabolismo , Diabetes Mellitus Experimental/sangre , Medicamentos Herbarios Chinos/farmacología , Lípidos/sangre , Plantago , Animales , Proteínas Sanguíneas , Supervivencia Celular/efectos de los fármacos , Células Cultivadas , Colesterol/sangre , Medicamentos Herbarios Chinos/aislamiento & purificación , Células Endoteliales/citología , Células Endoteliales/metabolismo , Prueba de Tolerancia a la Glucosa , Glicoproteínas/sangre , Humanos , Hipoglucemiantes/farmacología , Hipolipemiantes/farmacología , Masculino , Malondialdehído/metabolismo , Ratones , Ratones Endogámicos ICR , Óxido Nítrico/sangre , Páncreas/patología , Plantago/química , Plantas Medicinales/química , Superóxido Dismutasa/metabolismo , Venas Umbilicales/citología , Proteínas Séricas Glicadas
15.
J Pharm Pharmacol ; 56(10): 1299-305, 2004 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-15482645

RESUMEN

We used rats with streptozotocin (STZ)-induced diabetes to investigate the effects of Hachimi-jiogan on diabetic oxidative stress. Oral administration of Hachimi-jio-gan, at a dose of 50, 100 or 200 mg kg(-1) (body weight) daily, for 10 days to rats with STZ-induced diabetes resulted in significant dose-dependent decreases in serum levels of glucose and glycosylated protein, implying that Hachimi-jio-gan improves the abnormal glucose metabolism that leads to oxidative stress. Hachimi-jio-gan also showed a tendency to reduce the urine volume and significantly reduced the elevated urinary protein level. Moreover, rats with STZ-induced diabetes had high serum levels of superoxide and nitrite/nitrate. However, the administration of Hachimi-jio-gan dose-dependently reduced the overproduction of radicals associated with diabetes, suggesting the role of Hachimijio-gan as a radical scavenger that could protect against diabetic oxidative stress. Furthermore, thiobarbituric acid-reactive substance levels in serum and hepatic and renal mitochondria were dose-dependently lower in the Hachimi-jio-gan-treated groups than in the control diabetic group, which implies that Hachimi-jio-gan would alleviate the oxidative stress associated with diabetes through the inhibition of lipid peroxidation. These results indicate that Hachimi-jio-gan is a potential therapeutic agent that will reduce the damage caused by oxidative stress involved in diabetes.


Asunto(s)
Diabetes Mellitus Experimental/tratamiento farmacológico , Medicamentos Herbarios Chinos/uso terapéutico , Estrés Oxidativo/efectos de los fármacos , Fitoterapia , Animales , Glucemia/análisis , Proteínas Sanguíneas , Creatinina/sangre , Diabetes Mellitus Experimental/inducido químicamente , Diabetes Mellitus Experimental/metabolismo , Modelos Animales de Enfermedad , Medicamentos Herbarios Chinos/química , Glicoproteínas/sangre , Peroxidación de Lípido/efectos de los fármacos , Masculino , Nitratos/sangre , Nitritos/sangre , Proteinuria , Ratas , Ratas Wistar , Estreptozocina , Superóxidos/sangre , Aumento de Peso/efectos de los fármacos , Proteínas Séricas Glicadas
16.
Diabetes Care ; 18(6): 807-16, 1995 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-7555507

RESUMEN

OBJECTIVE: To evaluate the effect of vitamin E supplementation on the susceptibility of low-density lipoprotein (LDL) and LDL subfractions to oxidation and on protein glycation in non-insulin-dependent diabetes mellitus (NIDDM). RESEARCH DESIGN AND METHODS: Twenty-one men with NIDDM (HbA1c = 6-10%), ages 50-70, were randomly assigned to either 1,600 IU/day of vitamin E or placebo for 10 weeks after a 4-week placebo period. LDL and LDL subfractions were isolated after 4 weeks of placebo and after 6 and 10 weeks of therapy. Susceptibility of LDL to copper-mediated oxidation was measured by conjugated diene formation (lag time) and formation of thiobarbituric acid-reactive substances (TBARS). Fasting serum glucose, mean weekly blood glucose, HbA1c, and glycated plasma protein concentrations were also determined at these time points. RESULTS: Vitamin E content in plasma and LDL increased 4.0- and 3.7-fold, respectively, in the vitamin E-treated group. Vitamin E decreased the susceptibility of LDL to oxidation in comparison with placebo (lag time, 243 +/- 46 vs. 151 +/- 22 min, P < 0.01; 3 h TBARS, 24 +/- 12 vs. 66 +/- 18 nmol malondialdehyde/mg LDL, P < 0.05). Vitamin E content also increased significantly in both buoyant and dense LDL subfractions, and their oxidation was dramatically reduced. The lag time of LDL oxidation correlated well with the content of vitamin E in both LDL and its subfractions (r = 0.69-0.92). Glycemic indexes did not change significantly in either group during the study. Protein glycation, including glycated hemoglobin, glycated albumin, glycated total plasma proteins, and glycated LDL were unchanged in the vitamin E group. CONCLUSIONS: Supplementation of vitamin E in NIDDM leads to enrichment of LDL and LDL subfractions and reduced susceptibility to oxidation. Despite a greater percentage increase in vitamin E content in small dense LDL, it remained substantially more susceptible to oxidation than was buoyant LDL. This suggests that dense, LDL may gain less protection against oxidation from antioxidant supplementation than does larger, more buoyant LDL. In contrast to previous reports, vitamin E supplementation did not reduce glycation of intracellular or plasma proteins.


Asunto(s)
Diabetes Mellitus Tipo 2/sangre , Diabetes Mellitus Tipo 2/tratamiento farmacológico , Glicoproteínas , Lipoproteínas LDL/sangre , Vitamina E/uso terapéutico , Anciano , Glucemia/metabolismo , Proteínas Sanguíneas/análisis , Colesterol/sangre , HDL-Colesterol/sangre , LDL-Colesterol/sangre , Cobre , Fructosamina , Hemoglobina Glucada/análisis , Productos Finales de Glicación Avanzada , Glicosilación , Hexosaminas/análisis , Homeostasis , Humanos , Insulina/sangre , Lipoproteínas LDL/efectos de los fármacos , Masculino , Persona de Mediana Edad , Oxidación-Reducción , Albúmina Sérica/análisis , Sustancias Reactivas al Ácido Tiobarbitúrico , Factores de Tiempo , Triglicéridos/sangre , Vitamina E/sangre , Proteínas Séricas Glicadas , Albúmina Sérica Glicada
17.
Lab Delo ; (7): 12-5, 1991.
Artículo en Ruso | MEDLINE | ID: mdl-1724025

RESUMEN

Hyperbaric oxygenation (HBO) effects on the levels of circulating glycosylated proteins with various life spans in the blood stream (glycosylated hemoglobin (GH) and serum glycosylated fructose amine (SF) were studied in diabetes mellitus patients not suffering from vascular complications but developing various microangiopathies. Measurements of blood glycosylated proteins and mean daily glycemia carried out over the course of HBO treatment in the diabetics without microangiopathies evidenced an essential reduction of blood GH, SF, and glucose, reaching, in some cases, the normal values. Patients with vascular involvement (lower limb angiopathy, nephropathy, retinopathy) exposed to HBO developed but a trend to reduction of blood levels of glycosylated proteins and glucose. These results indicate a positive therapeutic effect of HBO courses on the status of diabetics with slightly manifest microvascular involvement. In cases with grave vascular involvement exposure to HBO appears inefficient.


Asunto(s)
Proteínas Sanguíneas/análisis , Diabetes Mellitus Tipo 1/sangre , Diabetes Mellitus Tipo 2/sangre , Glicoproteínas , Oxigenoterapia Hiperbárica , Adolescente , Adulto , Diabetes Mellitus Tipo 1/terapia , Diabetes Mellitus Tipo 2/terapia , Femenino , Humanos , Masculino , Persona de Mediana Edad , Proteínas Séricas Glicadas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA